Current Assets
Derivative assets
ResMed Derivative assets decreased by 1.6% to $7.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.3%, from $9.90M to $7.39M. Over 3 years (FY 2022 to FY 2025), Derivative assets shows an upward trend with a 249.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalHigher is better
VolatilityVolatile
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
An increase suggests that the company's hedging strategies are effectively capturing market gains or that market conditions have moved in favor of the company's positions.
Detailed definition
This represents the aggregate fair value of all derivative financial instruments that are currently in a net gain positi...
Peer comparison
Standardized metric for companies with active treasury and risk management departments.
Metric ID:
fin_derivative_assetsHistorical Data
15 periods
| Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $160.00K | $14.62M | $5.45M | $2.41M | $4.33M | $21.37M | $1.81M | $2.43M | $24.66M | $12.56M | $9.90M | $6.81M | $8.07M | $7.52M | $7.39M |
| QoQ Change | — | >999% | -62.7% | -55.9% | +80.0% | +393.9% | -91.5% | +34.4% | +914.1% | -49.1% | -21.1% | -31.2% | +18.5% | -6.9% | -1.6% |
| YoY Change | — | — | — | >999% | — | +46.2% | -66.8% | +1.1% | +469.9% | -41.3% | +447.1% | +180.0% | -67.3% | -40.1% | -25.3% |
Range$160.00K – $24.66M
CAGR+199.0%
Avg YoY Growth+209.7%
Median YoY Growth+1.1%
Current Streak2 quarters decline
Derivative assets at Other Companies
Frequently Asked Questions
- What is ResMed's derivative assets?
- ResMed (RMD) reported derivative assets of $7.39M in Q1 2026.
- How has ResMed's derivative assets changed year-over-year?
- ResMed's derivative assets decreased by 25.3% year-over-year, from $9.90M to $7.39M.
- What is the long-term trend for ResMed's derivative assets?
- Over 3 years (2022 to 2025), ResMed's derivative assets has grown at a 249.1% compound annual growth rate (CAGR), from $160.00K to $6.81M.
- What does derivative assets mean?
- The total value the company would receive if it closed out all its derivative contracts that are currently making money.